|
|
Between 1999 and 2012, American adults with high total cholesterol decreased from 18.3% to 12.9%
For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.
This year, an estimated 1.4 million Americans will have a new or recurrent heart attack.
Women are 50% to 75% more likely than men to experience an adverse drug reaction.
Though newer “smart” infusion pumps are increasingly becoming more sophisticated, they cannot prevent all programming and administration errors. Health care professionals that use smart infusion pumps must still practice the rights of medication administration and have other professionals double-check all high-risk infusions.